WuXi Leads $30 Million Funding for AltheaDx of San Diego

WuXi Healthcare Ventures of Shanghai led a $30 million Series C financing for AltheaDx, a commercial stage pharmacogenetics diagnostics company located in San Diego. AltheaDx said the round would enable outcome trials for its IDgenetix ® testing portfolio and expand its commercialization. AltheaDx's bioinformatics platform and PGx product testing portfolio are designed to identify the best drug for individual patients as well as dosing levels and possible drug-drug interactions.  More details.... Share this with colleagues: // //